During the past decade, North Texas Clinical Trials conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Texas Clinical Trials" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Naurex, Inc, an affiliate of Allergan plc" with 4 trials sponsored, "Sunovion" with 4 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Texas Clinical Trials" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "H. Lundbeck A/S" with 1 trials as a collaborator and "Tanox" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "North Texas Clinical Trials" are "Depressive Disorder, Major" (8 trials), "Asthma" (3 trials), "Perennial Allergic Rhinitis" (2 trials), "Schizophrenia" (2 trials) and "Acute Mania" (1 trials). Many other conditions were trialed in "North Texas Clinical Trials" in a lesser frequency.

Most popular intervention types in "North Texas Clinical Trials" are "Drug" (22 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Rapastinel" (4 trials), "Aticaprant" (2 trials), "Ecopipam" (2 trials) and "Seltorexant" (2 trials). Other intervention names were less common.

The vast majority of trials in "North Texas Clinical Trials" are 24 trials for "All" genders.

Currently, there are NaN active trials in "North Texas Clinical Trials". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in North Texas Clinical Trials, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in North Texas Clinical Trials, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".